SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018056
Filing Date
2019-05-09
Accepted
2019-05-09 16:38:29
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q myok-10q_20190331.htm 10-Q 1933797
2 EX-31.1 myok-ex311_9.htm EX-31.1 15759
3 EX-31.2 myok-ex312_6.htm EX-31.2 15843
4 EX-32.1 myok-ex321_8.htm EX-32.1 8707
  Complete submission text file 0001564590-19-018056.txt   6620992

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT myok-20190331.xml EX-101.INS 1448945
6 XBRL TAXONOMY EXTENSION SCHEMA myok-20190331.xsd EX-101.SCH 52780
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myok-20190331_cal.xml EX-101.CAL 48193
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myok-20190331_def.xml EX-101.DEF 136476
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20190331_lab.xml EX-101.LAB 361730
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20190331_pre.xml EX-101.PRE 275997
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37609 | Film No.: 19811219
SIC: 2834 Pharmaceutical Preparations